Agents and Actions

, Volume 28, Issue 1–2, pp 9–15 | Cite as

The effect of azelastine and some other antiasthmatic and antiallergic drugs on calmodulin and protein kinase C

  • E. MiddletonJr.
  • P. Ferriola
  • G. Drzewiecki
  • R. Duane Sofia
Allergy, Histamine and Kinins

Abstract

The antiallergic and antiasthmatic drug, azelastine, interacts strongly with calmodulin (but not bovine serum albumin) as determined by an indirect assay; it also moderately inhibited the Ca2+-calmodulindependent enzyme bovine brain phosphodiesterase. Ketotifen was less active than azelastine in both assays of calmodulin reactivity and both drugs were less active than the recognized calmodulin inhibitor, W-7. Neither azelastine nor ketotifen had any inhibitory effect on the Ca2+- and phospholipid-dependent protein kinase C. A number of other commonly employed antiallergic and antiasthmatic drugs were essentially inactive in the calmodulin assays and had no or marginal inhibitory effect on protein kinase C.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. [1]
    A. Mandi, G. Galgoczy, E. Galambos and R. Aurich,Histamine protection and bronchodilation with azelatine, a new antiallergic compound. Bull. Eur. Physiopathologic Respiratoire17 (1), 5P (1981).Google Scholar
  2. [2]
    P. Atkins, H. Merton, P. Karpink, I. Weliky and B. Zweiman,Azelastine inhibition of skin test reactivity in humans. J. Allergy Clin. Immunol.75 (1), 167 (1985)Google Scholar
  3. [3]
    S. Motojima, Y. Ohashi, T. Otsuk, T. Fukuda and S. Makino,Effects of azelastine on allergen- and exercise-induced asthma. Asian Pacific J. Allergy Immun.3, 174–178 (1985).Google Scholar
  4. [4]
    S. L. Spector, J. L. Perhach, A. S. Rohr, G. S. Rachelefsky, R. M. Katz and S. C. Siegel,Pharmacodynamic evaluation of azelastine in subjects with asthma. J. Allergy Clin. Immunol.80, 75–80 (1987).PubMedGoogle Scholar
  5. [5]
    S. Ollier, C. A. L. Gould and R. J. Davies,The effect of single and multiple dose therapy with azelastine on the immediate asthmatic response to allergen provocation testing. J. Allergy Clin. Immunol.78, 358–364 (1986).PubMedGoogle Scholar
  6. [6]
    N. Chand, J. Pillar, W. Diamantis, J. L. Perhach Jr. and R. D. Sofia,Inhibition of calcium ionophore (A23187)-stimulated histamine release from rat peritoneal mast cells by azelastine: implications for its mode of action. Europ. J. Pharmacol.96, 227–233 (1983).Google Scholar
  7. [7]
    N. Chand, J. Pillar, W. Diamantis and R. D. Sofia,Inhibition of IgE-mediated allergic histamine release from rat peritoneal mast cells by azelastine and selected antiallergic drugs. Agents and Actions16 (5), 318–322 (1985).PubMedGoogle Scholar
  8. [8]
    D. A. S. Fields, J. Pillar, W. Diamantis, J. L. Perhach Jr., R. D. Sofia and N. Chand,Inhibition by azelastine of nonallergic histamine release from rat peritoneal mast cells. J. Allergy Clin. Immunol.73 (3), 400–403 (1984).PubMedGoogle Scholar
  9. [9]
    N. Chand, J. Pillar, W. Diamantis and R. D. Sofia,Inhibition of allergic histamine release by azelastine and selected antiallergic drugs from rabgit leukocytes. Int. Arch. Allergy Apply. Immunol.77, 451–455 (1985).Google Scholar
  10. [10]
    M. M. Little and T. B. Casale,Azelastine inhibits both human lung and basophil degranulation. J. Allergy Clin. Immunol.79 (1), 204 (1987).Google Scholar
  11. [11]
    N. Chand, J. Pillar, K. Nolan, W. Diamantis and R. D. Sofia,Inhibition of 5-HETE, LTB 4 and LTC 4 synthesis by azelastine and its d- and l-isomers in rat mixed peritoneal cells. Amer. Rev. Resp. Dis.135, A318 (1987).Google Scholar
  12. [12]
    N. Chand, W. Diamantis, K. Nolan, J. Pillar and R. D. Sofia,Inhibition of allergic leukotriene C 4 (LTC 4)formation by azelastine in actively sensitized chopped guinea pig lung. Pharmacologist29, 173 (1987).Google Scholar
  13. [13]
    K. Taniguchi, and K. Takanaka,Inhibitory effects of various drugs on phorbol myristate acetate and n-formyl-methionyl-leucyl-phenulalanine induced O 2 production in polymorphonuclear leukocytes. Biochem. Pharmacol.33 (20), 3165–3169 (1984).PubMedGoogle Scholar
  14. [14]
    N. Chand, W. Diamantis and R. D. Sofia, Antagonism of leukotrienses, calcium and histamine by azelastine. Pharmacologist26, 152 (1984).Google Scholar
  15. [15]
    N. Chand, W. Diamantis and R. D. Sofia, Antagonism of histamine and leukotrienes by azelastine in isolated guinea pig ileum. Agents and Actions19 (3–4), 164–168 (1986).PubMedGoogle Scholar
  16. [16]
    N. Chand, K. Nolan, W. Diamantis, J. L. Perhach and R. D. Sofia,Inhibition of leukotriene (SRS-A)-mediated acute lung anaphylaxis by azelastine in guinea pigs. Allergy41, 473–478 (1986).PubMedGoogle Scholar
  17. [17]
    N. Chand, K. Nolan, W. Diamantis and R. D. Sofia,Inhibition of acute lung anaphylaxis by aerosolized azelastine in guinea pigs sensitized by three different procedures. Annals of Allergy58 (5), 344–349 (1987).PubMedGoogle Scholar
  18. [18]
    N. Chand, J. E. Harrison, S. M. Rooney, R. D. Sofia and W. Diamantis,Inhibition of passive cutaneous anaphylaxis (PCA) by azelastine: dissociation of its antiallergic activities from antihistaminic and antiserotonin properties. Int. J. Immunopharmacol.7 (6), 833–838 (1985).PubMedGoogle Scholar
  19. [19]
    A. R. Means, J. S. Task and J. G. Chafouleas,Physiological implications of the presence, distribution, and regulation of calmodulin ineukaryotic cells. Physiol. Res.62, 1–39 (1982).Google Scholar
  20. [20]
    G. Marone, M. Columbo, S. Poto, R. Giugliano and M. Condorelli,Possible role of calmodulin in the control of histamine release from human basophil leukocytes. Life Sci.39, 911–922 (1986).PubMedGoogle Scholar
  21. [21]
    H. Hidaka, M. Asano, S. Iwadare, I. Matsumoto, T. Totsuka and N. Aoki,A novel vascular relaxing agent, N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide which affects vascular smooth muscle actomyosin. J. Pharmacol. Exp. Ther.207, 8–15 (1978).PubMedGoogle Scholar
  22. [22]
    Y. Nishizuka,Studies and perspectives of protein kinase C. Science233, 305–312 (1986).PubMedGoogle Scholar
  23. [23]
    H. Nishino, A. Naito Iwashima, K. Tanaka, T. Matsuura, H. Fujiki and T. Sugimura,Interaction between quercetin and Ca 2+-calmodulin complex: Possible mechanism for antitumor-promoting action of the flavonoid. Gann74, 311–316 (1984).Google Scholar
  24. [24]
    H. Hidaka and T. Tanaka,Naphthalenesulfonamides as calmodulin antagonists. Methods Enzymol.102, 185–194.Google Scholar
  25. [25]
    R. W. Butcher and E. W. Sutherland,Adenosine 3′, 5′-phosphate in biological materials. I. Purification and properties of cyclic 3′, 5′-nucleotide phosphodiesterase and use of this enzyme to characterize adenosine 3′, 5′-phosphate in human urine. J. Biol. Chem.237, 1244–1250 (1962).PubMedGoogle Scholar
  26. [26]
    C. H. Fiske and Y. SubbaRow,Colorimetric determination of phosphorous. J. Biol. Chem.66, 375–400 (1925).Google Scholar
  27. [27]
    U. Kikkawa, Y. Takai, R. Minakuchi, S. Inohara and Y. Nishizuka,Calcium-activated, phospholipid-dependent protein kinase from rat brain. Subcellular distribution, purification and properties. J. Biol. Chem.257, 13341–13348 (1982).PubMedGoogle Scholar
  28. [28]
    I. H. Segel, In:Enzyme Kinetics: Behavior and Analysis of Rapid Equilbrium and Steady-State Enzyme Systems, pp. 71 and 217, John Wiley & Sons, New York.Google Scholar
  29. [29]
    M. M. Bradford,A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dyne binding. Anal. Biochem.72, 248–254 (1976).PubMedGoogle Scholar
  30. [30]
    M. Gschwendt, F. Horn, W. Kittstein and F. Marrks,Inhibition of the calcium- and phospholipid-dependent protein kinase activity from mouse brain cytosol by quercetin. Biochem. Biophys. Res. Comm.177, 444–447 (1983).Google Scholar
  31. [31]
    P. M. Epstein, K. Fiss, R. Hachisu and D. M. Andrenyak,Interaction of calcium antagonists with cyclic AMP phosphodiesterases and calmodulin. Biochem. Biophys. Res. Commun.105, 1142–1149 (1982).PubMedGoogle Scholar

Copyright information

© Birkhäuser Verlag 1989

Authors and Affiliations

  • E. MiddletonJr.
    • 1
  • P. Ferriola
    • 1
  • G. Drzewiecki
    • 1
  • R. Duane Sofia
    • 2
  1. 1.Department of Medicine State University of New York at BuffaloBuffaloUSA
  2. 2.Wallace LaboratoriesCranburyUSA

Personalised recommendations